tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Technical Analysis

468 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Verve Therapeutics’s (VERV) Moving Averages Convergence Divergence (MACD) indicator is 0.16, suggesting Verve Therapeutics is a Sell.
Verve Therapeutics’s (VERV) 20-Day exponential moving average is 5.63, while Verve Therapeutics’s (VERV) share price is $7.16, making it a Buy.
Verve Therapeutics’s (VERV) 50-Day exponential moving average is 6.12, while Verve Therapeutics’s (VERV) share price is $7.16, making it a Buy.

Verve Therapeutics (VERV) Pivot Points

Jul 20, 2024, 07:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.83
6.06
6.22
6.45
6.61
6.84
7.00
Fibonacci
6.06
6.21
6.30
6.45
6.60
6.69
6.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verve Therapeutics (VERV) Moving Averages

Jul 20, 2024, 07:47 PM
Period
Simple
Exponential
MA5
6.22Buy
6.22Buy
MA10
5.64Buy
5.87Buy
MA20
5.42Buy
5.63Buy
MA50
5.60Buy
6.12Buy
MA100
8.48Sell
7.70Sell
MA200
10.45Sell
10.07Sell
Verve Therapeutics’s (VERV) 10-Day exponential moving average is 5.87, while Verve Therapeutics’s (VERV) share price is $7.16, making it a Buy.
Verve Therapeutics’s (VERV) 100-Day exponential moving average is 7.70, while Verve Therapeutics’s (VERV) share price is $7.16, making it a Sell.
Verve Therapeutics’s (VERV) stock price is $7.16 and Verve Therapeutics’s (VERV) 50-day simple moving average is 5.60, creating a Buy signal.
Verve Therapeutics’s (VERV) stock price is $7.16 and Verve Therapeutics’s (VERV) 100-day simple moving average is 8.48, creating a Sell signal.
Verve Therapeutics’s (VERV) stock price is $7.16 and Verve Therapeutics’s (VERV) 200-day simple moving average is 10.45, creating a Sell signal.

Verve Therapeutics (VERV) Technical Indicators

Jul 20, 2024, 07:47 PM
Name
Value
Implied Action
RSI (14)
70.76
Sell
STOCH (9,6)
81.39
Sell
STOCHRSI (14)
81.78
Sell
MACD (12,26)
0.16
Sell
ADX (14)
23.30
Neutral
Williams %R
-16.37
Sell
CCI (14)
211.66
Sell
ATR (14)
0.43
-
Ultimate Oscillator
56.51
Neutral
ROC
27.22
Buy
Verve Therapeutics’s (VERV) Relative Strength Index (RSI) is 70.76, creating a Sell signal.
Verve Therapeutics’s (VERV) Trend Strength Indicator (ADX) is 23.30, creating a Neutral signal.
Verve Therapeutics’s (VERV) Commodity Channel Index (CCI) is 211.66, creating a Sell signal.
Verve Therapeutics’s (VERV) Price Rate of Change (ROC) is 27.22, creating a Buy signal.

FAQ

Is VERV a Buy, Hold, or Sell?
Based on VERV’s technical indicators, VERV is a Hold.
    What is VERV’s RSI (14)?
    VERV’s RSI (14) is 70.76, which suggests VERV is a Sell.
      What is VERV’s MACD?
      VERV’s MACD is 0.16, which suggests VERV is a Sell.
        What is VERV’s 5-day moving average?
        VERV’s 5-day moving average is 6.22, which suggests VERV is a Buy.
          What is VERV’s 20-day moving average?
          VERV 20-day moving average is 5.42, which suggests VERV is a Buy.
            What is VERV’s 50-day moving average?
            VERV’s 50-day moving average is 5.60, which suggests VERV is a Buy.
              What is VERV’s 200-day moving average?
              VERV’s 200-day moving average is 10.45, which suggests VERV is a Sell.
                What is VERV’s Williams % R (14)?
                VERV’s Williams % R (14) is -16.37, which suggests VERV is a Sell.
                  What is VERV’s CCI (14)?
                  VERV’s CCI (14) is 211.66, which suggests VERV is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis